BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects

被引：10

作者：

Apostolou, Vivi ^{[1
]}

Fostira, Florentia ^{[1
]}

Kouroussis, Charalambos ^{[2
]}

Kalfakakou, Despoina ^{[1
]}

Delimitsou, Angeliki ^{[1
]}

Agelaki, Sofia ^{[3
,4
]}

Androulakis, Nikolaos ^{[5
]}

Christodoulou, Christos ^{[6
]}

Kalbakis, Konstantinos ^{[4
]}

Kalykaki, Antonia ^{[4
]}

Sanidas, Elias ^{[7
]}

Papadimitriou, Christos ^{[8
]}

Vamvakas, Lambros ^{[4
]}

Georgoulias, Vassilis ^{[9
]}

Mavroudis, Dimitris ^{[3
,4
]}

Yannoukakos, Drakoulis ^{[1
]}

Konstantopoulou, Irene ^{[1
]}

Saloustros, Emmanouil ^{[10
]}

机构：

[1] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, INRaSTES, Athens, Greece

[2] Gen Clin IASIS, Khania, Crete, Greece

[3] Univ Crete, Sch Med, Lab Translat Oncol, Iraklion, Crete, Greece

[4] Univ Hosp Heraklion, Sch Med, Dept Med Oncol, Iraklion, Greece

[5] Gen Hosp Heraklion Venizelio Pananio, Iraklion, Greece

[6] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece

[7] Univ Crete, Sch Med, Dept Surg, Iraklion, Greece

[8] Natl & Kapodistrian Univ Athens, Aretaie Hosp, Dept Surg 2, Oncol Unit, Athens, Greece

[9] Hellen Oncol Res Grp HORG, Athens, Greece

[10] Univ Thessaly, Fac Med, Sch Hlth Sci, Larisa, Greece

来源：

INTERNATIONAL JOURNAL OF CANCER | 2020年 / 147卷 / 05期

关键词：

BRCA; hereditary; breast; ovarian cancer; germline mutations; founder mutations; BREAST/OVARIAN CANCER FAMILIES; HAPLOTYPE ANALYSIS; MUTATION CARRIERS; BREAST; OVARIAN; RISK; REARRANGEMENTS; VARIANTS; GENE; DNA;

D O I：

10.1002/ijc.32903

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

GermlineBRCA1andBRCA2loss-of-function variants have been linked to increased breast and ovarian cancer risk, with more than 5,000 distinct pathogenic variants being reported worldwide. Among individuals of Greek descent, theBRCA1/2variant spectrum is heterogeneous, but characterized by strong founder effects. As patients from certain geographical regions of Greece (like Crete) were underrepresented in previous studies, we hypothesized that isolated Cretans, a southern Greece islanders' population with distinct demographic, cultural and genetic features, could harbor founderBRCA1/2mutations. A total of 304 breast or/and ovarian cancer patients of Cretan descent, fulfilling NCCN criteria for genetic testing, were tested by NGS or Sanger sequencing, followed by MLPA. Haplotype analysis was subsequently performed to investigate potential founder effects of recurrent alleles. Overall, 16.5% (50/304) of the tested patients carried 22 different pathogenic variants; 48% inBRCA1, 52% inBRCA2. Three variants, namely two inBRCA2(Delta exons 12 and 13 and c.7806-2A>T) and one inBRCA1(c.5492del), constituting approximately half (48%) of all detected pathogenic variants, were shown to have a founder effect, with all carriers sharing common haplotypes. Remarkably, these variants were confined to Cretans and have not been identified in other regions of Greece. The high prevalence of specificBRCA1/2 pathogenic variants among Cretans, provides the possibility of cost- and time-efficient screening of the Cretan population. Integrating this knowledge in local public health services may have a significant impact on cancer prevention, and may serve as a starting point for the implementation of testing on a population level.

引用

页码：1334 / 1342

页数：9

共 40 条

[1] Functional Classification of BRCA2 DNA Variants by Splicing Assays in a Large Minigene with 9 Exons [J].

Acedo, Alberto ;

Hernandez-Moro, Cristina ;

Curiel-Garcia, Alvaro ;

Diez-Gomez, Beatriz ;

Velasco, Eladio A. .

HUMAN MUTATION, 2015, 36 (02) :210-221

[2] G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients:: evaluation of its pathogenicity and inferences on its genealogical history [J].

Anagnostopoulos, Theodore ;

Pertesi, Maroulio ;

Konstantopoulou, Irene ;

Armaou, Sofia ;

Kamakari, Smaragda ;

Nasioulas, George ;

Athanasiou, Athanassios ;

Dobrovic, Alex ;

Young, Mary-Anne ;

Goldgar, David ;

Fountzilas, George ;

Yannoukakos, Drakoulis .

BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (02) :377-385

[3] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].

Antoniou, A ;

Pharoah, PDP ;

Narod, S ;

Risch, HA ;

Eyfjord, JE ;

Hopper, JL ;

Loman, N ;

Olsson, H ;

Johannsson, O ;

Borg, Å ;

Pasini, B ;

Radice, P ;

Manoukian, S ;

Eccles, DM ;

Tang, N ;

Olah, E ;

Anton-Culver, H ;

Warner, E ;

Lubinski, J ;

Gronwald, J ;

Gorski, B ;

Tulinius, H ;

Thorlacius, S ;

Eerola, H ;

Nevanlinna, H ;

Syrjäkoski, K ;

Kallioniemi, OP ;

Thompson, D ;

Evans, C ;

Peto, J ;

Lalloo, F ;

Evans, DG ;

Easton, DF .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130

[4] Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation [J].

Apostolou, P. ;

Pertesi, M. ;

Aleporou-Marinou, V. ;

Dimitrakakis, C. ;

Papadimitriou, C. ;

Razis, E. ;

Christodoulou, C. ;

Fountzilas, G. ;

Yannoukakos, D. ;

Konstantopoulou, I. ;

Fostira, F. .

CLINICAL GENETICS, 2017, 91 (03) :482-487

[5]

Apostolou PVA, 2015, BREAST CANC SUSCEPTI, P1

[6] Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain) [J].

Blay, Pilar ;

Santamaria, Inigo ;

Pitiot, Ana S. ;

Luque, Maria ;

Alvarado, Marta G. ;

Lastra, Ana ;

Fernandez, Yolanda ;

Paredes, Angeles ;

Freije, Jose M. P. ;

Balbin, Milagros .

BMC CANCER, 2013, 13

[7] The contribution of germline rearrangements to the spectrum of BRCA2 mutations [J].

Casilli, F. ;

Tournier, I. ;

Sinilnikova, O. M. ;

Coulet, F. ;

Soubrier, F. ;

Houdayer, C. ;

Hardouin, A. ;

Berthet, P. ;

Sobol, H. ;

Bourdon, V. ;

Muller, D. ;

Fricker, J. P. ;

Capoulade-Metay, C. ;

Chompret, A. ;

Nogues, C. ;

Mazoyer, S. ;

Chappuis, P. ;

Maillet, P. ;

Philippe, C. ;

Lortholary, A. ;

Gesta, P. ;

Bezieau, S. ;

Toulas, C. ;

Gladieff, L. ;

Maugard, C. M. ;

Provencher, D. M. ;

Dugast, C. ;

Delvincourt, C. ;

Nguyen, T. D. ;

Faivre, L. ;

Bonadona, V. ;

Frebourg, T. ;

Lidereau, R. ;

Stoppa-Lyonnet, D. ;

Tosi, M. .

JOURNAL OF MEDICAL GENETICS, 2006, 43 (09) :e49

[8] BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2 [J].

Cline, Melissa S. ;

Liao, Rachel G. ;

Parsons, Michael T. ;

Paten, Benedict ;

Alquaddoomi, Faisal ;

Antoniou, Antonis ;

Baxter, Samantha ;

Brody, Larry ;

Cook-Deegan, Robert ;

Coffin, Amy ;

Couch, Fergus J. ;

Craft, Brian ;

Currie, Robert ;

Dlott, Chloe C. ;

Dolman, Lena ;

den Dunnen, Johan T. ;

Dyke, Stephanie O. M. ;

Domchek, Susan M. ;

Easton, Douglas ;

Fischmann, Zachary ;

Foulkes, William D. ;

Garber, Judy ;

Goldgar, David ;

Goldman, Mary J. ;

Goodhand, Peter ;

Harrison, Steven ;

Haussler, David ;

Kato, Kazuto ;

Knoppers, Bartha ;

Markello, Charles ;

Nussbaum, Robert ;

Offit, Kenneth ;

Plon, Sharon E. ;

Rashbass, Jem ;

Rehm, Heidi L. ;

Robson, Mark ;

Rubinstein, Wendy S. ;

Stoppa-Lyonnet, Dominique ;

Tavtigian, Sean ;

Thorogood, Adrian ;

Zhang, Can ;

Zimmermann, Marc ;

Burn, John ;

Chanock, Stephen ;

Ratsch, Gunnar ;

Spurdle, Amanda B. ;

Andreoletti, Gaia ;

Baker, Dixie ;

Brenner, Steven ;

Brush, Matthew .

PLOS GENETICS, 2018, 14 (12)

[9] NCCN Guidelines® Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines [J].

Daly, Mary B. ;

Pilarski, Robert ;

Berry, Michael ;

Buys, Saundra S. ;

Farmer, Meagan ;

Friedman, Susan ;

Garber, Judy E. ;

Kauff, Noah D. ;

Khan, Seema ;

Klein, Catherine ;

Kohlmann, Wendy ;

Kurian, Allison ;

Litton, Jennifer K. ;

Madlensky, Lisa ;

Merajver, Sofia D. ;

Offit, Kenneth ;

Pal, Tuya ;

Reiser, Gwen ;

Shannon, Kristen Mahoney ;

Swisher, Elizabeth ;

Vinayak, Shaveta ;

Voian, Nicoleta C. ;

Weitzel, Jeffrey N. ;

Wick, Myra J. ;

Wiesner, Georgia L. ;

Dwyer, Mary ;

Darlow, Susan .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (01) :9-19

[10] HGVS Recommendations for the Description of Sequence Variants: 2016 Update [J].

den Dunnen, Johan T. ;

Dalgleish, Raymond ;

Maglott, Donna R. ;

Hart, Reece K. ;

Greenblatt, Marc S. ;

McGowan-Jordan, Jean ;

Roux, Anne-Francoise ;

Smith, Timothy ;

Antonarakis, Stylianos E. ;

Taschner, Peter E. M. .

HUMAN MUTATION, 2016, 37 (06) :564-569

← 1 2 3 4 →